Revance Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Revance Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Revance Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 136 %, a 92.3% decline year-over-year.
  • Revance Therapeutics, Inc. annual Return On Equity for 2023 was 503 %.
  • Revance Therapeutics, Inc. annual Return On Equity for 2022 was -787 %, a 333% decline from 2021.
  • Revance Therapeutics, Inc. annual Return On Equity for 2021 was -182 %, a 111% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 136 -1.64K -92.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 237 +1.14K Apr 1, 2024 Jun 30, 2024
Q1 2024 385 +1.48K Jan 1, 2024 Mar 31, 2024
Q4 2023 503 +1.29K Oct 1, 2023 Dec 31, 2023
Q3 2023 1.77K +2.23K Jul 1, 2023 Sep 30, 2023
Q2 2023 -903 -406 -81.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.09K -817 -299% Jan 1, 2023 Mar 31, 2023
Q4 2022 -787 -605 -333% Oct 1, 2022 Dec 31, 2022
Q3 2022 -462 -333 -260% Jul 1, 2022 Sep 30, 2022
Q2 2022 -498 -395 -383% Apr 1, 2022 Jun 30, 2022
Q1 2022 -274 -180 -192% Jan 1, 2022 Mar 31, 2022
Q4 2021 -182 -95.7 -111% Oct 1, 2021 Dec 31, 2021
Q3 2021 -128 -42.5 -49.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -103 -14.1 -15.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -93.6 -8.41 -9.87% Jan 1, 2021 Mar 31, 2021
Q4 2020 -86.1 -4.96 -6.12% Oct 1, 2020 Dec 31, 2020
Q3 2020 -85.7 +1.87 +2.14% Jul 1, 2020 Sep 30, 2020
Q2 2020 -89 -9.69 -12.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -85.2 -9.88 -13.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -81.1 -7.43 -10.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -87.6 -24.1 -37.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -79.3 -13.8 -21.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -75.3 -9.29 -14.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -73.7 -6.74 -10.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -63.5 +4.31 +6.35% Jul 1, 2018 Sep 30, 2018
Q2 2018 -65.5 -10.3 -18.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -66 -16 -32% Jan 1, 2018 Mar 31, 2018
Q4 2017 -66.9 -23.9 -55.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -67.9 -30.5 -81.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -55.2 -14.8 -36.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -50 -10.1 -25.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -43 -1.48 -3.57% Oct 1, 2016 Dec 31, 2016
Q3 2016 -37.3 +4.27 +10.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -40.4 -4.73 -13.2% Apr 1, 2016 Jun 30, 2016
Q1 2016 -39.9 -8.58 -27.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -41.5 -2.28 -5.81% Oct 1, 2015 Dec 31, 2015
Q3 2015 -41.6 +34.9 +45.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -35.7 Apr 1, 2015 Jun 30, 2015
Q1 2015 -31.3 Jan 1, 2015 Mar 31, 2015
Q4 2014 -39.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 -76.5 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.